Log in to save to my catalogue

SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship

SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_033234423a3249f782bc308007b821a1

SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship

About this item

Full title

SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship

Publisher

Egypt: Hindawi

Journal title

Applied bionics and biomechanics, 2022-04, Vol.2022, p.1-8

Language

English

Formats

Publication information

Publisher

Egypt: Hindawi

More information

Scope and Contents

Contents

Objective. Endometrial carcinoma (EC) ranks first in the incidence of female genital malignancies in developed countries. SPOP (speckle-type POZ protein) has changed in EC with a statistically high frequency. This research may play a crucial role in the initiation and progression of EC, ultimately leading to fresh therapeutic targets. Explore the e...

Alternative Titles

Full title

SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_033234423a3249f782bc308007b821a1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_033234423a3249f782bc308007b821a1

Other Identifiers

ISSN

1176-2322

E-ISSN

1754-2103

DOI

10.1155/2022/5721630

How to access this item